NO20006444L - Referanseforbindelse for anvendelse i ananlyser av levosimendanporsjoner - Google Patents

Referanseforbindelse for anvendelse i ananlyser av levosimendanporsjoner

Info

Publication number
NO20006444L
NO20006444L NO20006444A NO20006444A NO20006444L NO 20006444 L NO20006444 L NO 20006444L NO 20006444 A NO20006444 A NO 20006444A NO 20006444 A NO20006444 A NO 20006444A NO 20006444 L NO20006444 L NO 20006444L
Authority
NO
Norway
Prior art keywords
levosimendan
analysis
portions
reference compound
compound
Prior art date
Application number
NO20006444A
Other languages
English (en)
Other versions
NO20006444D0 (no
NO325393B1 (no
Inventor
Reijo Baeckstroem
Tuula Heinonen
Tuula Hauta-Aho
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20006444D0 publication Critical patent/NO20006444D0/no
Publication of NO20006444L publication Critical patent/NO20006444L/no
Publication of NO325393B1 publication Critical patent/NO325393B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N2030/042—Standards
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
NO20006444A 1998-06-18 2000-12-15 Forbindelse, referansepreparat som inneholder forbindelsen, anvendelse av forbindelsen til a bestemme genotoksiske urenheter og fremgangsmater derav NO325393B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981428A FI104718B (fi) 1998-06-18 1998-06-18 [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä
PCT/FI1999/000539 WO1999065888A2 (en) 1998-06-18 1999-06-18 A reference compound for use in the analysis of levosimendan batches

Publications (3)

Publication Number Publication Date
NO20006444D0 NO20006444D0 (no) 2000-12-15
NO20006444L true NO20006444L (no) 2000-12-15
NO325393B1 NO325393B1 (no) 2008-04-21

Family

ID=8552039

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006444A NO325393B1 (no) 1998-06-18 2000-12-15 Forbindelse, referansepreparat som inneholder forbindelsen, anvendelse av forbindelsen til a bestemme genotoksiske urenheter og fremgangsmater derav

Country Status (28)

Country Link
US (1) US6340764B1 (no)
EP (1) EP1087956B1 (no)
JP (1) JP4550279B2 (no)
KR (1) KR100661772B1 (no)
CN (1) CN1129590C (no)
AR (1) AR018879A1 (no)
AT (1) ATE253566T1 (no)
AU (1) AU755699B2 (no)
BR (1) BR9911230A (no)
CA (1) CA2334864C (no)
CZ (1) CZ298659B6 (no)
DE (1) DE69912604D1 (no)
EA (1) EA002854B1 (no)
ES (1) ES2211113T3 (no)
FI (1) FI104718B (no)
HK (1) HK1032779A1 (no)
HR (1) HRP20000866B1 (no)
HU (1) HU229582B1 (no)
ID (1) ID29239A (no)
IL (1) IL139964A (no)
MX (1) MXPA00012436A (no)
NO (1) NO325393B1 (no)
NZ (1) NZ508557A (no)
PL (1) PL201772B1 (no)
RS (1) RS49929B (no)
SK (1) SK284353B6 (no)
WO (1) WO1999065888A2 (no)
ZA (1) ZA200006993B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012220A (es) 2004-04-21 2007-07-18 Teva Pharma Procesos para preparar sodio de montelukast.
FR2877013A1 (fr) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
CA2608369A1 (en) 2005-07-05 2007-01-11 Teva Pharmaceutical Industries Ltd. Purification of montelukast
CN104230816B (zh) * 2014-09-19 2017-02-15 成都新恒创药业有限公司 一种左西孟旦潜在基因毒性杂质及其制备、检测方法
CN104478809B (zh) * 2014-11-14 2016-08-17 成都新恒创药业有限公司 一种左西孟旦杂质及其制备和检测方法
CN105817632A (zh) * 2015-01-09 2016-08-03 中国科学院宁波材料技术与工程研究所 片状粉末的制备装置及方法
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB383449A (en) * 1931-12-12 1932-11-17 Percy Charles Barton Improvements relating to masts, poles, or like supports and their manufacture
GB565546A (en) * 1943-04-13 1944-11-15 Leslie Frederick Reeve A pneumatically operated pickup unit for use in electric organs and the like
FI894035A (fi) * 1988-09-07 1990-03-08 Orion Yhtymae Oy Foerfarande foer framstaellning av nya substituerade pyridazinoner.
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
GB9915179D0 (en) * 1999-06-29 1999-09-01 Orion Corp A method for the treatment or prevention of coronary graft vasospasm

Also Published As

Publication number Publication date
FI104718B (fi) 2000-03-31
JP4550279B2 (ja) 2010-09-22
US6340764B1 (en) 2002-01-22
EA200100055A1 (ru) 2001-06-25
IL139964A0 (en) 2002-02-10
HUP0102020A2 (hu) 2001-12-28
CN1306527A (zh) 2001-08-01
KR100661772B1 (ko) 2006-12-28
HU229582B1 (en) 2014-02-28
NO20006444D0 (no) 2000-12-15
MXPA00012436A (es) 2002-06-04
CZ298659B6 (cs) 2007-12-12
EA002854B1 (ru) 2002-10-31
ES2211113T3 (es) 2004-07-01
EP1087956B1 (en) 2003-11-05
SK18722000A3 (sk) 2001-09-11
DE69912604D1 (de) 2003-12-11
ZA200006993B (en) 2002-02-28
NZ508557A (en) 2002-05-31
EP1087956A2 (en) 2001-04-04
PL201772B1 (pl) 2009-05-29
FI981428A0 (fi) 1998-06-18
CZ20004555A3 (en) 2001-05-16
CA2334864C (en) 2008-01-15
JP2002518383A (ja) 2002-06-25
WO1999065888A3 (en) 2000-01-27
KR20010072622A (ko) 2001-07-31
BR9911230A (pt) 2001-03-06
SK284353B6 (sk) 2005-02-04
FI981428A (fi) 1999-12-19
NO325393B1 (no) 2008-04-21
CN1129590C (zh) 2003-12-03
PL347577A1 (en) 2002-04-08
AR018879A1 (es) 2001-12-12
CA2334864A1 (en) 1999-12-23
HRP20000866B1 (en) 2009-02-28
HK1032779A1 (en) 2001-08-03
ATE253566T1 (de) 2003-11-15
ID29239A (id) 2001-08-16
AU4786399A (en) 2000-01-05
HRP20000866A2 (en) 2001-12-31
RS49929B (sr) 2008-09-29
YU76700A (sh) 2002-11-15
IL139964A (en) 2003-07-06
WO1999065888A2 (en) 1999-12-23
AU755699B2 (en) 2002-12-19
HUP0102020A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
DE69931795D1 (de) Mikrosensor
DE69930518D1 (de) Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate
LTPA2009006I1 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
IS5699A (is) Ný notkun
FI4209U1 (fi) Uusia yhdisteitä
ID27004A (id) Senyawa-senyawa kalsilitik
DE69930340D1 (de) Reibahle
NO20006662L (no) Fluorfenylresin-forbindelser
NO20006444D0 (no) Referanseforbindelse for anvendelse i ananlyser av levosimendanporsjoner
DK1135381T3 (da) Eletriptanhydrobromidmonohydrat
DE59804880D1 (de) Melder
DE69902955D1 (de) Microtome
DK199801743A (da) Sum-intervaldetektor
DE69901643T2 (de) Reibahle
FI971253A (fi) Lyoluminesenssin käyttö analyyttisiin tarkoituksiin
DE29802627U1 (de) Küvette
SE9800834D0 (sv) New Compounds
SE9800511D0 (sv) New compounds
SE9803746D0 (sv) New compounds
SE9800977D0 (sv) New compounds
SE9801099D0 (sv) New compounds
SE9803747D0 (sv) New compounds
SE9800508D0 (sv) New Compounds

Legal Events

Date Code Title Description
MK1K Patent expired